Position in CYTK
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$111,740,655
+$39,669,060 QoQ
Shares Held
1,311,664
+20.0% QoQ
Ownership
0.943%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#24
of 477 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRINCIPAL FINANCIAL GROUP INC holds $1,852,088,599 across 105 Biotechnology names. CYTK ranks #3 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
873,502 | $232,980,453 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
389,511 | $193,481,798 | |
| 3 | CYTK |
Cytokinetics Inc
This page
|
1,311,664 | $111,740,655 | |
| 4 | GPCR |
Structure Therapeutics Inc.
|
1,752,753 | $94,070,253 | |
| 5 | INSM |
INSMED Inc
|
856,126 | $91,280,154 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
332,642 | $81,420,782 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
1,024,423 | $76,299,024 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
121,053 | $75,481,386 |
All Filings in CYTK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $111,740,655 | 1,311,664 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $72,071,595 | 1,093,485 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $62,071,716 | 976,892 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $64,547,661 | 1,174,448 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $39,145,956 | 1,184,805 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $25,316,122 | 629,911 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $12,754,096 | 271,133 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $14,418,729 | 273,082 | Shares | Defined | 2024-10-31 | |
| 2024-06-30 | $21,324,109 | 393,579 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $30,256,390 | 431,556 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $43,512,649 | 521,172 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $15,474,836 | 525,283 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $18,127,422 | 555,715 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $20,512,390 | 582,904 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $30,487,894 | 665,384 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $29,673,057 | 612,447 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $26,452,699 | 673,268 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $24,226,427 | 658,148 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $30,862,946 | 677,116 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $21,416,515 | 599,231 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $10,351,772 | 523,081 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $12,042,143 | 517,719 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $10,743,571 | 517,015 | Shares | Defined | 2021-02-23 | |
| 2020-09-30 | $11,395,693 | 526,360 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $10,976,242 | 465,687 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $5,392,026 | 457,339 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||